Reagent compounds, compositions, kits, and methods for amplified assays
The instant disclosure provides reagent compounds, and antibody and oligonucleotide reagents, for use in a variety of assays, including immunoassays and nucleic acid hybridizations. The reagent compounds comprise a bridging antigen or bridging oligonucleotide and a latent crosslinker moiety, such as a tyramide moiety. The bridging antigens are recognizable by the antibody of a corresponding antibody reagent with high affinity, and the bridging oligonucleotides are complementary to the oligonucleotide of a corresponding oligonucleotide reagent. The antibody reagents and oligonucleotide reagents also comprise a crosslinker activation agent, such as a peroxidase enzyme. Reaction of the reagent compounds with the crosslinker activation agent results in the amplification of signal in assays for target cellular markers, including cellular antigens and nucleic acids. Also provided are detectable antibodies specific for the bridging antigens, kits comprising the reagent compounds and antibody and oligonucleotide reagents, methods of signal amplification using the compounds and reagents of the disclosure, methods of preparation of the compounds and reagents, and compositions comprising the compounds and reagents.
1. A diagnostic kit comprising:
a first reagent compound comprising a bridging peptide coupled to a tyramide moiety, said bridging peptide being selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5;
a first detectable antibody having specificity for the bridging peptide with high affinity, wherein the first detectable antibody comprises a detectable label, said first detectable antibody being a monoclonal antibody; and
instructions for use.
2. The kit of claim 1 , wherein the first detectable antibody is specific for the bridging peptide with a dissociation constant of at most 1 nM.
3. The kit of claim 1 , wherein the detectable label is a fluorophore, an enzyme, an upconverting nanoparticle, a quantum dot, or a detectable hapten.
4. The kit of claim 3 , wherein the detectable label is a fluorophore.
5. The kit of claim 1 , wherein the detectable label is a peroxidase, an alkaline phosphatase, or a glucose oxidase.
6. The kit of claim 1 , further comprising a first antibody reagent; wherein the first antibody reagent comprises an antibody and a crosslinker activation agent.
7. The kit of claim 6 , wherein the crosslinker activation agent comprises an enzyme.
8. The kit of claim 7 , wherein the enzyme is a peroxidase, an alkaline phosphatase, or a glucose oxidase.
9. The kit of claim 8 , wherein the enzyme is a peroxidase.
10. The kit of claim 9 , wherein the peroxidase is a horseradish peroxidase or a soybean peroxidase.
11. The kit of claim 6 , wherein the antibody of the first antibody reagent is specific for a cellular marker.
12. The kit of claim 11 , wherein the cellular marker is a target protein.
13. The kit of claim 6 , wherein the antibody of the first antibody reagent is specific for a cross-species immunoglobulin.
14. The kit of claim 1 , further comprising a second detectable antibody and a second reagent compound.
15. The kit of claim 14 , further comprising a first antibody reagent and a second antibody reagent;
wherein each antibody reagent comprises an antibody and a crosslinker activation agent.
16. The kit of claim 11 , wherein the cellular marker is Ki-67.
17. A diagnostic kit comprising a tyramide labeled reagent, said tyramide labeled reagent comprising a bridging peptide coupled to a tyramide moiety, wherein said bridging peptide is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO: 5.